Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2759 Results
Genomes of Chimpanzee Parasite Species Reveal Evolution of Human Malaria, According to Penn-led Study

Genomes of Chimpanzee Parasite Species Reveal Evolution of Human Malaria, According to Penn-led Study

Understanding the origins of emerging diseases – as well as more established disease agents -- is critical to gauge future human infection risks and find new treatment and prevention approaches. This holds true for malaria, which kills more than 500,000 people a year. Symptoms, including severe anemia, pregnancy-associated malaria, and cerebral malaria, have been linked to the parasite’s ability to cause infected red blood cells to bind to the inner lining of blood vessels.

Karen Kreeger

Penn, University of Michigan VA-led Study: Antipsychotic Drugs Linked to Increased Mortality Among Parkinson's Disease Patients

Penn, University of Michigan VA-led Study: Antipsychotic Drugs Linked to Increased Mortality Among Parkinson's Disease Patients

At least half of Parkinson’s disease patients experience psychosis at some point during the course of their illness, and physicians commonly prescribe antipsychotic drugs, such as quetiapine, to treat the condition. However, a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, the University of Michigan Medical School, and the Philadelphia and Ann Arbor Veterans Affairs (VA) Medical Centers and suggests that these drugs may do significantly more harm in a subset of patients. The findings will be published in the March 21 issue of JAMA Neurology.

Lee-Ann Donegan

Penn Vet Study Identifies Mechanism Explaining Female Bias in Autoimmunity

Penn Vet Study Identifies Mechanism Explaining Female Bias in Autoimmunity

Possessing two X chromosomes is a double-edged sword, immunologically speaking. Females are better at fighting off infection than males, but they are also more susceptible to many autoimmune conditions, such as lupus.

Katherine Unger Baillie

Penn Biochemist Receives Protein Society Award

Penn Biochemist Receives Protein Society Award

Benjamin Aaron Garcia, PhD, a Presidential Professor of Biochemistry and Biophysics at the Perelman School of Medicine at the University of Pennsylvania, has been selected to receive the 2016Protein Science Young Investigator Award.

Karen Kreeger

Penn Researchers Show Rising Opioid Prescriptions Following Low-Risk Surgeries

Penn Researchers Show Rising Opioid Prescriptions Following Low-Risk Surgeries

Physicians are prescribing more opioid painkillers than ever before to patients undergoing common surgeries, according to new research from the department of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania.

Lee-Ann Donegan

Penn Medicine Wins NIH Award to Study Progressive Brain Damage from Concussions and More Severe Traumatic Brain Injuries

Penn Medicine Wins NIH Award to Study Progressive Brain Damage from Concussions and More Severe Traumatic Brain Injuries

An international team of investigators led by experts at the Perelman School of Medicine at the University of Pennsylvania has been awarded a nearly $3 million, five-year grant from the National Institute of Neurological Disorders and Stroke (NINDS) to establish diagnostic criteria for chronic traumatic encephalopathy (CTE).

Lee-Ann Donegan

Penn Study: In-Car Breathalyzers for DUI Offenders Curb Drunk-Driving Deaths by 15 Percent

Penn Study: In-Car Breathalyzers for DUI Offenders Curb Drunk-Driving Deaths by 15 Percent

State laws that require drivers who’ve been convicted of drunk driving to pass a breathalyzer-type test before starting their cars saved an estimated 915 lives between 2004 and 2013, according to a study published in the American Journal of Public Health by researchers at the Perelman School of Medicine at th

Greg Richter

Penn Study Suggests Reduced Immunosuppression Drug Dose May Be Best for Kidney Transplant Outcomes

Penn Study Suggests Reduced Immunosuppression Drug Dose May Be Best for Kidney Transplant Outcomes

The kidney is the most commonly transplanted organ in the United States, with more than 17,000 transplants performed each year. Following kidney transplant, patients are routinely placed on a regimen of immunosuppressant medications to prevent organ rejection, which often includes calcineurin inhibitors (CNIs) as the backbone medication of this regimen.

Abbey Anderson